P3‐059: THE EVALUATION OF MOLECULAR MECHANISMS AND TRANSLATIONAL BIOMARKERS OF MITOCHONDRIA‐TARGETING THERAPEUTICS IN SYMPTOMATIC AD MICE. (1st July 2019)